NEUREN PHARMA (NEU)
Follow NEUREN PHARMA (NEU) with live pricing, a 12-month performance chart against Australia benchmarks, dividends history, and tools to compare this stock with peers on the ASX.
Returns Summary
| Ticker | Month-to-Date | Year-to-Date | 12-Month Return |
|---|---|---|---|
| NEU | + 0,85% | + 14,08% | + 16,20% |
| S&P/ASX 200 | + 1,11% | + 1,57% | + 3,71% |
| S&P/ASX 20 | + 0,85% | + 6,09% | + 7,00% |
| S&P/ASX 50 | + 0,87% | + 3,18% | + 2,96% |
| S&P/ASX 100 | + 1,06% | + 2,18% | + 3,17% |
| S&P/ASX 300 | + 1,11% | + 1,30% | + 3,86% |
| S&P/ASX Midcap | + 2,31% | - 3,75% | + 5,15% |
| ASX All Ordinaries | + 0,92% | + 0,56% | + 3,47% |
12-Month Snapshot
Monthly Returns
| Ticker | 2025-07 | 2025-08 | 2025-09 | 2025-10 | 2025-11 | 2025-12 | 2026-01 | 2026-02 | 2026-03 | 2026-04 | 2026-05 | 2026-06 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NEU | - 0,56% | + 20,37% | + 0,15% | - 7,28% | - 0,57% | - 9,99% | - 2,40% | - 6,68% | + 2,39% | + 5,41% | + 14,50% | + 0,85% |
| S&P/ASX 200 | + 2,35% | + 2,63% | - 1,39% | + 0,37% | - 3,57% | + 1,74% | + 1,78% | + 3,72% | - 5,73% | - 0,07% | + 0,76% | + 1,11% |
| S&P/ASX 20 | + 2,24% | + 2,02% | - 2,28% | + 0,65% | - 4,79% | + 3,08% | + 1,56% | + 7,50% | - 4,12% | - 0,14% | + 0,42% | + 0,85% |
| S&P/ASX 50 | + 2,10% | + 1,59% | - 2,02% | + 0,12% | - 4,17% | + 2,16% | + 1,68% | + 5,13% | - 4,96% | - 0,16% | + 0,61% | + 0,87% |
| S&P/ASX 100 | + 2,38% | + 2,06% | - 1,76% | + 0,22% | - 3,70% | + 1,79% | + 1,58% | + 4,34% | - 5,44% | - 0,10% | + 0,74% | + 1,06% |
| S&P/ASX 300 | + 2,42% | + 2,70% | - 1,25% | + 0,41% | - 3,54% | + 1,81% | + 1,72% | + 3,50% | - 5,85% | - 0,03% | + 0,87% | + 1,11% |
| S&P/ASX Midcap | + 4,24% | + 5,15% | - 0,11% | + 0,85% | - 0,86% | - 0,37% | + 1,01% | - 0,46% | - 8,47% | + 0,29% | + 1,58% | + 2,31% |
| ASX All Ordinaries | + 2,58% | + 2,71% | - 1,16% | + 0,46% | - 3,40% | + 1,72% | + 1,62% | + 2,95% | - 5,83% | + 0,02% | + 0,87% | + 0,92% |
Price Performance — 1Y
Dividends History — NEUREN PHARMA (NEU)
Recent dividends for NEUREN PHARMA (NEU) over the last 12 months, including amount per share and a 100-share simulation.
| Payment Date | Amount per Share | Simulation (100 shares) |
|---|---|---|
| 2025-09-15 | A$ 2,75 | A$ 275,00 |
| 2025-12-15 | A$ 3,00 | A$ 300,00 |
| 2026-03-16 | A$ 3,00 | A$ 300,00 |
| 2026-06-15 | A$ 3,00 | A$ 300,00 |
Compare NEUREN PHARMA (NEU)
Benchmark NEUREN PHARMA (NEU) against other Australia stocks. Pick a quick-compare ticker below or search by symbol to open a side-by-side page with normalized 12-month charts, monthly returns, market benchmarks, and dividend tables for each name.
About NEUREN PHARMA (NEU)
NEUREN PHARMA (NEU) is a Australia stock listed on the Australian Securities Exchange (ASX). This page gives you a single view of today's price and daily change, a normalized 12-month chart plotted alongside major indices such as S&P/ASX 200, ASX All Ordinaries, and a returns table with month-to-date (MTD), year-to-date (YTD), and 12-month performance so you can judge how NEU moved relative to the broader market.
Below the chart, the dividends section lists recent payouts for NEUREN PHARMA (NEU), including payment dates, amount per share, and a 100-unit simulation. For income-focused investors, combining price appreciation with dividends gives a clearer picture of total return than price alone. Use the period buttons on the chart (1M, 3M, 6M, 12M) to zoom into shorter time frames when reviewing recent momentum.
Scroll to the compare section to benchmark NEU against other Australia stocks. Pick a quick-compare pill or search for any ticker to open a side-by-side page with normalized charts, monthly returns, benchmark lines, and separate dividends tables. SaveMoneyToInvest is a free research tool — not financial advice. Past performance does not guarantee future results.
Frequently Asked Questions
- Where can I see the live price of NEUREN PHARMA (NEU)?
- The price card at the top of this page shows the current quote for NEU, today's percentage change, and the previous close. Data is sourced from public market feeds and refreshed during trading hours on the ASX.
- How has NEU performed over the last 12 months?
- The interactive chart plots NEU's normalized 12-month price performance alongside Australia benchmarks including S&P/ASX 200, ASX All Ordinaries. The returns table below the chart summarizes MTD, YTD, and 12-month percentage change so you can compare NEUREN PHARMA to the broader market at a glance.
- Does NEUREN PHARMA (NEU) pay dividends?
- The dividends table on this page lists recent payouts for NEU over the last 12 months, including payment dates and amounts per share. If no payments appear, the company or fund may not have distributed dividends during that window.
- How do I compare NEU with other Australia stocks?
- Use the "Compare NEU" section near the bottom of this page. Click a quick-compare pill or search for another ticker to open a dedicated comparison with side-by-side charts, monthly returns, benchmarks, and dividends history for each name.
- Is the data on this NEU page financial advice?
- No. SaveMoneyToInvest provides market data and research tools for informational purposes only. Nothing on this page constitutes investment, tax, or legal advice. Always verify quotes with your broker and consult a licensed financial advisor before making investment decisions.